| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132679 Induction of pancreatic islet formation |
| 07/08/2004 | US20040132676 Polynucleotide formulation for enhanced intracellular transfer |
| 07/08/2004 | US20040132667 Compositions containing mixtures of tetrapeptides and tripeptides |
| 07/08/2004 | US20040132666 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 07/08/2004 | US20040132665 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
| 07/08/2004 | US20040132664 Conjugated kringle peptide fragment coupled to a functionalized polyoxyethyene glycol, polyoxypropylene glycol or copolymer thereof; anticarcinogenic, antiarthritic, antidiabetic,and antitumor agents; hemangiomas, psoriasis |
| 07/08/2004 | US20040132663 Nervous system, cardiovascular, and psychological disorder treatment; anticonvulsant agents, neuroprotectants, analgesics; headaches; snail venom |
| 07/08/2004 | US20040132662 Angiogenesis inhibition by contacting tumor or animal tissue with polypeptide comprising one or more isolated NCl (non-collagenous) alpha chain monomers of type IV collagen ; vision defects; antitumor and antimetastasis agents |
| 07/08/2004 | US20040132661 Therapeutic method for treating bone formation diseases |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132659 Contortrostatin CN and methods for its use in preventing metastasis and other conditions |
| 07/08/2004 | US20040132658 Administering polypeptide with extracellular region having deletion, replacement or other mutation and an amino acid sequence comprising Phe-Asp-Pro-Pro-Pro-Phe to inhibit transmission of a costimulatory signal of lymphocytes |
| 07/08/2004 | US20040132657 Method of treating allergen induced airway disease |
| 07/08/2004 | US20040132656 Blood-coagulation factor VIII (or antihemophilic factor) containing trehalose stabilizer in absence of albumin; reconstitution with water |
| 07/08/2004 | US20040132655 New combination |
| 07/08/2004 | US20040132654 Increased content of high molecular weight multimers; hemophilia and blood disorder treatment |
| 07/08/2004 | US20040132653 Lyophilized composition of bone morphogenetic factor human MP52 |
| 07/08/2004 | US20040132651 Administering modulating agent comprising histidine-alanine-valine tripeptide to treat demyelinating nervous system disorders such as multiple sclerosis; inhibits cadherin-mediated cell adhesion |
| 07/08/2004 | US20040132650 Human growth hormone for treating children with abnormal short stature and kits and methods for diagnosing gs protein dysfunctions |
| 07/08/2004 | US20040132649 Blood coagulation factor XIII for treating platelet disorders |
| 07/08/2004 | US20040132648 Remedies and/or preventives for conformational diseases |
| 07/08/2004 | US20040132647 Amidated glucagon-like peptide-1 |
| 07/08/2004 | US20040132645 Methods for modulating effects of radiation in a subject |
| 07/08/2004 | US20040132644 Composition and method for treating diabetes |
| 07/08/2004 | US20040132643 Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms |
| 07/08/2004 | US20040132642 Methods of inhibiting metastasis or growth of a tumor cell |
| 07/08/2004 | US20040132641 Fas peptide mimetics and uses thereof |
| 07/08/2004 | US20040132639 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 07/08/2004 | US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 07/08/2004 | US20040132635 Method for prevention and treatment of kidney diseases |
| 07/08/2004 | US20040132634 Compositions and methods for regulating the kinase domain of receptor tyrosine kinases |
| 07/08/2004 | US20040132617 Having His-Phe-Asp-Leu-Ser-Gly motif; plant derived; more effective on monocotyledon than dicotyledon cells; paper and textile processing |
| 07/08/2004 | US20040132190 Comprises genetically engineered adenoviral coding therapeutic agents as marker protein for use as gene transfer/drug delivery tool in cardiac diagnostic catheterization |
| 07/08/2004 | US20040132188 Mixture comprising modified peptides for use as facilatory tool in gene and protein transfer into cells; gene therapy; drug delivery |
| 07/08/2004 | US20040132185 Cd8alphadendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 07/08/2004 | US20040132179 Treatment of t cell disorders |
| 07/08/2004 | US20040132178 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 07/08/2004 | US20040132164 Methods and compositions for inhibiting adhesion by microorganisms |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132161 Methods and compositions for increasing CD4lymphocyte immune responsiveness |
| 07/08/2004 | US20040132160 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 07/08/2004 | US20040132159 Novel beta-secretase and modulation of beta-secretase activity |
| 07/08/2004 | US20040132155 Comprises nucleotide sequences coding hydrolase for use in identifying modulators for treatment of cancer, inflammatory, nervous system, autoimmune, asthmatic, reproductive and atherosclerotic disorders; enzyme inhibitors |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease |
| 07/08/2004 | US20040132136 Comprises viricidal polypeptide for prevention and treatment of viral diseases; antiproliferative agents |
| 07/08/2004 | US20040132134 Identification of a novel bitter taste receptor, T2R76 |
| 07/08/2004 | US20040132120 Cell regulatory genes, encoded products, and uses related thereto |
| 07/08/2004 | US20040132105 by blotting assays and affinity chromatography of activated platelets or activated endothelial cell (labeled HL-60 cell) extracts |
| 07/08/2004 | US20040132097 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors |
| 07/08/2004 | US20040132093 Comprises cytokine receptor fusion protein for use in indentifying modulators for treatment of bone disorders |
| 07/08/2004 | US20040132087 Novel human enzyme family members and uses thereof |
| 07/08/2004 | US20040132085 Mammalian cell membrane proteins; related reagents |
| 07/08/2004 | US20040132078 Oligonucleotides for controlling expression of gene products associated with mitochondrial membranes, which bind insulin sensitizing, antidiabetic thiazolodinediones (mitoNEET) for treatment of diabetes, cardiovascular and nervous system defects |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132053 Sphingosine kinase enzyme |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132028 Collection of repeat proteins comprising repeat modules |
| 07/08/2004 | US20040132023 Regulation of human caspase-1-like protease |
| 07/08/2004 | US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents |
| 07/08/2004 | US20040132021 Using presence of genetic variation in van buchem-sclerosteosis disease region to identify disorders resulting in either net excess bone formation or insufficient bone formation in humans; allelicvariation and bone disorders |
| 07/08/2004 | US20040132020 Novel enzyme gene and its expression product |
| 07/08/2004 | US20040131711 Bowman-birk inhibitor concentrate product and process |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131681 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 07/08/2004 | US20040131666 Liposome encapsulating active materials |
| 07/08/2004 | US20040131632 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/08/2004 | US20040131630 Administering a attenuated bacteria ; nucleic acids; induce immunology response |
| 07/08/2004 | US20040131626 Administering a genetic engineered polypeptide |
| 07/08/2004 | US20040131619 Thymic atrophy |
| 07/08/2004 | US20040131618 Anticancer agents; diagnosis using alternation of gene expression |
| 07/08/2004 | US20040131616 Methods of inhibiting proliferative diseases |
| 07/08/2004 | US20040131611 Antitumor agents, anticancer agents; synergistic mixture |
| 07/08/2004 | US20040131608 Antibodies; suppression, therapy, prevention |
| 07/08/2004 | US20040131606 Product and process for liquefaction of mucus for sputum |
| 07/08/2004 | US20040131605 Therapy for genetic disorders; purification by chromatography |
| 07/08/2004 | US20040131604 Methods for inhibiting viral replication in vivo |
| 07/08/2004 | US20040131601 Injection of bone marrow-derived cells and medium for angiogenesis |
| 07/08/2004 | US20040131600 Method of preventing adhesions by apoptosis of adhesion peritoneal cells |
| 07/08/2004 | US20040131598 Cancer therapy |
| 07/08/2004 | US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents |
| 07/08/2004 | US20040131593 Neuronal gene transfer |
| 07/08/2004 | US20040131589 Materials and methods for inhibition of IgE production |
| 07/08/2004 | US20040131588 Formulation having mobilising activity |
| 07/08/2004 | US20040131587 Administering mixture of dendritic cells, apoptosis or necrosis agents,chemattractants |
| 07/08/2004 | US20040131585 Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 07/08/2004 | US20040131497 Process for sterilization of biological compositions containg protein |
| 07/08/2004 | US20040129638 Multi-part substitution infusion fluids and matching anticoagulants |
| 07/08/2004 | DE10257771A1 Inhibierung der HIV Replikation durch Expression von 'late domain' Peptiden in Zielzellen Inhibition of HIV replication by expression of 'late domain' peptides in target cells |
| 07/08/2004 | DE10257770A1 Expression von Peptiden des zytoplasmatischen Bereiches von HIV-gp41 zur Hemmung viraler Infektionen Expression of peptides of the cytoplasmic region of HIV gp41 to inhibit viral infections |
| 07/08/2004 | CA2512215A1 An immunomodulatory protein derived from trypanosomes and uses thereof |
| 07/08/2004 | CA2511451A1 Biomedical devices with antimicrobial coatings |
| 07/08/2004 | CA2511144A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | CA2510787A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| 07/08/2004 | CA2510780A1 Method of treating angiogenic tissue growth |
| 07/08/2004 | CA2510715A1 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | CA2510459A1 Means for preventing and curing endocrine system disturbances |
| 07/08/2004 | CA2510199A1 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |